Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer

Clinical trial NCT06121570 · RECRUITING

Trial details

NCT number: NCT06121570
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2023-11-01
Primary completion: 2026-08-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.